Table 2 Clinical Outcomes for EPO treatment vs no EPO treatment in AKI patients
From: Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial
Patients without EPO n = 67 | Patients treated with EPO n = 67 | Risk Ratio | 95%Confidence Interval | p | |
|---|---|---|---|---|---|
Primary outcome, n(%) | |||||
Transfusions | 22 (32.8) | 23 (34.3) | 1.05 | 0.65, 1.68 | 0.855 |
Secondary outcomes, n(%) | |||||
Renal recovery to baseline, full or partial | 54 (80.6) | 52 (77.6) | 0.96 | 0.81, 1.15 | 0.671 |
Dialysis | 0 (0) | 5 (7.5) | 11.00 | 0.62, 195.08 | 0.102 |
Death | 7 (10.4) | 10 (14.9) | 1.43 | 0.58, 3.53 | 0.440 |